The estimated Net Worth of Robin L Smith is at least $227 Tisíc dollars as of 3 September 2021. Robin Smith owns over 175,000 units of Sorrento Therapeutics Inc stock worth over $2,350 and over the last 8 years he sold SRNE stock worth over $0. In addition, he makes $225,116 as Independent Director at Sorrento Therapeutics Inc.
Sign up
Robin Smith SRNE stock SEC Form 4 insiders trading
Robin has made over 3 trades of the Sorrento Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 175,000 units of SRNE stock worth $785,750 on 3 September 2021.
The largest trade he's ever made was exercising 175,000 units of Sorrento Therapeutics Inc stock on 3 September 2021 worth over $785,750. On average, Robin trades about 11,522 units every 24 days since 2016. As of 3 September 2021 he still owns at least 235,000 units of Sorrento Therapeutics Inc stock.
You can see the complete history of Robin Smith stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Robin Smith biography
Dr. Robin L. Smith M.D. serves as Independent Director of the Company. Dr. Smith has been recognized for her extensive leadership in the biopharmaceutical industry winning an array of industry awards and business recognitions. She received the Regenerative Medicine Foundation (RMF) 2019 Stem Cell and Regenerative Medicine Action Award for International Diplomacy in 2019, the 2018 HEALinc Future Health Humanitarian Award, the Business Intelligence Group's Woman of the Year Award in 2018 and the 2018 Gold Stevie® Award for Woman of the Year (Government or Non-Profit). In April 2016, Pope Francis awarded Dr. Smith Dame Commander with Star Pontifical Equestrian Order of Saint Sylvester Pope and Martyr and was awarded the Lifetime Achievement in Healthcare and Science by The National Museum of Catholic Art and Library. Dr. Smith is a 2016 recipient of the Women of Power and Influence Awards and winner of the 2014 Brava Award. She received her B.A. degree from Yale University and her M.D. degree from the Yale School of Medicine. Dr. Smith holds an M.B.A. degree from the Wharton School of Business and completed the Stanford University Directors Program and received an honorary Doctor of Science degree from Thomas Jefferson Medical College
What is the salary of Robin Smith?
As the Independent Director of Sorrento Therapeutics Inc, the total compensation of Robin Smith at Sorrento Therapeutics Inc is $225,116. There are 8 executives at Sorrento Therapeutics Inc getting paid more, with Jaisim Shah having the highest compensation of $10,971,100.
How old is Robin Smith?
Robin Smith is 55, he's been the Independent Director of Sorrento Therapeutics Inc since 2019. There are 9 older and 3 younger executives at Sorrento Therapeutics Inc. The oldest executive at Sorrento Therapeutics Inc is Dr. Michael A. Royal, 67, who is the SVP & Chief Medical Officer.
What's Robin Smith's mailing address?
Robin's mailing address filed with the SEC is C/O SORRENTO THERAPEUTICS, INC., 4955 DIRECTORS PLACE, SAN DIEGO, CA, 92121.
Insiders trading at Sorrento Therapeutics Inc
Over the last 15 years, insiders at Sorrento Therapeutics Inc have traded over $17,198,839 worth of Sorrento Therapeutics Inc stock and bought 10,353,437 units worth $10,703,222 . The most active insiders traders include Jane Ph D Hsiao, Edgar Lee a Patrick Chan Soon Shiong Fa.... On average, Sorrento Therapeutics Inc executives and independent directors trade stock every 60 days with the average trade being worth of $2,947. The most recent stock trade was executed by Henry Ji on 7 September 2022, trading 88,888 units of SRNE stock currently worth $179,554.
What does Sorrento Therapeutics Inc do?
sorrento therapeutics is an antibody-centric, clinical stage biopharmaceutical company developing new treatments for cancer, inflammation and autoimmune diseases. sorrento's lead products are multiple late-stage biosimilar and biobetter antibodies, as well as clinical car-t therapies targeting solid tumors.
What does Sorrento Therapeutics Inc's logo look like?
Complete history of Robin Smith stock trades at Rockwell Medical Inc, ServiceSource International Inc, Sorrento Therapeutics Inc a Seelos Therapeutics
Sorrento Therapeutics Inc executives and stock owners
Sorrento Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Jaisim Shah,
Director -
Henry Ji,
Chairman of the Board, President, Chief Executive Officer, Co-Founder -
Dr. Henry H. Ji Ph.D.,
Chairman, Pres & CEO -
Najjam Asghar,
Sr. VP & CFO -
Kim Janda,
Director -
Yue Wu,
Independent Director -
Dorman Followwill,
Lead Independent Director -
David Lemus,
Independent Director -
Robin Smith,
Independent Director -
Edgar Lee,
Independent Director -
Najjam Asghar,
Chief Financial Officer -
William J. Farley,
VP of Sales & Bus. Devel. -
Dr. Robert D. Allen Ph.D.,
Sr. VP of Antiviral & Immunotherapy -
Brian Cooley,
Sr. VP of Lymphatic Drug Delivery BU Leader -
Dr. Shawn Sahebi Ph.D.,
Sr. VP of Strategy & Analytics -
Dr. Mark R. Brunswick,
Sr. VP of Regulatory Affairs -
Dr. Alexis Nahama,
Sr. VP & Head of RTX Program -
Dr. Michael A. Royal,
SVP & Chief Medical Officer -
Bill Farley,
VP of Sales & Bus. Devel. -
Brian Sun,
Sr. VP, Gen. Counsel & Corp. Sec. -
Jane Ph D Hsiao,
Director -
Management Ltd Abg Srne Ltd...,
-
Douglas O Ebersole,
Director -
Jeffrey Su,
Executive VP and COO -
Kevin Herde,
Executive VP and CFO -
William S Marth,
Director -
Management Ltd Abg Srne Ltd...,
-
George K Ng,
See Remarks -
Patrick Chan Soon Shiong Fa...,
-
Jerome B Zeldis,
See Remarks -
David H Deming,
Director -
Antonius Schuh,
Chairman and CEO -
Steve Zaniboni,
Director -
Curtis Lockshin,
Director -
Donald R Scifres,
10% owner -
Diane D S Tang Liu,
Director -
Glenn L Halpryn,
Director -
Charles P Rodi,
VP, Research & Development -
Martina Molsbergen,
VP, Business Development -
Dean Ferrigno,
Chief Accounting Officer -
Pacific Med Tech (Bvi) Ltd ...,
-
Management Ltd Abg Srne Ltd...,
-
Management Ltd Abg Ii So Lt...,
-
Jiong Shao,
Chief Financial Officer -
Zhenwei Miao,
Chief Technology Officer -
George Uy,
Chief Commercial Officer -
Patrickmp 13 Ventures, Llc ...,
-
Michael Scott Salka,
Director -
Health, Inc. Opko,
10% owner -
Mark Durand,
Director -
Richard G Vincent,
Chief Financial Officer -
Cam Gallagher,
Director -
David Ritchie Webb,
Director -
Ernst Guenter Afting,
Director -
Vuong Trieu,
CSO -
Elizabeth Czerepak,
EVP & Chief Financial Officer -
Tammy Reilly,
Director